Platelet gel from cord blood: A novel tool for tissue engineering

References

• Gluckman E. History of cord blood transplantation. Bone Marrow Transplant 2009; 44: 621–626
   PubMed Web of Science ®Google Scholar
• McGuckin CP, Forraz N. Umbilical cord blood stem cells-an ethical source for regenerative medicine. Med Law 2008; 27: 147–165
   PubMedGoogle Scholar
• Brand A, Rebulla P, Engelfriet CP, Reesink HW, Beguin Y, Baudoux E, Kögler G, Ebrahimi M, Grazzini G, Costa AN, et al. Cord blood banking. Vox Sang 2008; 95: 335–348
   PubMedGoogle Scholar
• Rubinstein P. Cord blood banking for clinical transplantation. BMT 2009; 44: 635–642
   Google Scholar
• Garcia J. Allogeneic unrelated cord blood banking worldwide: An update. Transfus Apher Sci 2010; 42: 257–263
   PubMed Web of Science ®Google Scholar
• Kode JA, Mukherjee S, Joglekar MV, Hardikar AA. Mesenchymal stem cells: Immunology and role in immunomodulation and tissue regeneration. Cytotherapy 2009; 11: 377–391
   PubMed Web of Science ®Google Scholar
• Jurk K, Kehrel BE. Platelets: Physiology and biochemistry. Semin Thromb Hemost 2005; 31: 381–392
   PubMed Web of Science ®Google Scholar
• Driver VR, Hanft J, Fylling CP, Beriou JM. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage 2006; 52: 68–74
   PubMed Web of Science ®Google Scholar
• Gruber R, Varga F, Fischer MB, Watzek G. Platelets stimulate proliferation of bone cells: Involvement of platelet-derived growth factor, microparticles and membranes. Clin Oral Implants Res 2002; 13: 529–535
   PubMed Web of Science ®Google Scholar
• Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004; 91: 4–15
   PubMed Web of Science ®Google Scholar
• Frechette JP, Martineau I, Gagnon G. Platelet-rich plasmas: growth factor content and roles in wound healing. J Dent Res 2005; 84: 434–439
   PubMed Web of Science ®Google Scholar
• Carr ME, Carr SL, Tildon T, Fisher LM, Martin EJ. Batroxobin-induced clots exhibit delayed and reduced platelet contractile force in some patients with clotting factor deficiencies. J Thromb Haemost 2003; 1: 243–249
   PubMedGoogle Scholar
• Kubo T, Matsunaga T, Asai H, Kawamoto K, Kusakari J, Nomura Y, Oda M, Yanagita N, Niwa H, Uemura T, et al. Efficacy of defibrinogenation and steroid therapies on sudden deafness. Arch Otolaryngol Head Neck Surg 1988; 114: 649–652
   PubMed Web of Science ®Google Scholar
• Gusev EI, Skvortsova VI, Suslina ZA, Avakian GN, Martynov Mlu, Temirbaeva SL, Tanashian MA, Kamchtnov PR, Stakhovskaia LV, Efremova NM. Batroxobin in patients with ischemic stroke in the carotid system (the multicenter study). Zh Nevrol Psikhiatr Im S S Korsakova 2006; 106: 31–34
   PubMedGoogle Scholar
• Wang HT, Jiang WL, Zhang YN, Sun ZF, Sun QF, Ma J. Multicentre clinical observation of anticoagulation and thrombolysis for the deep venous thrombosis. Zhonghua Yi Xue Za Zhi 2009; 89: 3181–3185
   PubMedGoogle Scholar
• Zeng Z, Xiao P, Chen J, Wei Y. Are batroxobin agents effective for perioperative hemorrhage in thoracic surgery? A systematic review of randomized controlled trials. Blood Coagul Fibrinolysis 2009; 20: 101–107
   PubMedGoogle Scholar
• Zhang L, Lu SH, Li L, Tao YG, Wan YL, Senga H, Yang R, Han ZC. Batroxobin mobilizes circulating endothelial progenitor cells in patients with deep vein thrombosis. Clin Appl Thromb Hemost 2009; Oct 13. [Epub ahead of print].
   Google Scholar
• Sirchia G, Rebulla P, Mozzi F, Lecchi L, Lazzari L, Ratti I. A quality system for placental blood banking. Bone Marrow Transplant 1998; 21: 843
   Google Scholar
• Mazzucco L, Balbo V, Cattana E, Borzini P. Platelet-rich plasma and platelet gel preparation using Plateltex®. Vox Sang 2008; 94: 202–208
   PubMedGoogle Scholar
• Garcia A, Zitzmann N, Watson SP. Analyzing the platelet proteome. Semin Thromb Hemost 2004; 30: 485–489
   PubMedGoogle Scholar
• Everts PA, Knape JT, Weibrich G, Schonberger JP, Hoffmann J, Overdevest EP, Box HA, van Zundert A. Platelet-rich plasma and platelet gel: A review. J Extra Corpor Technol 2006; 38: 174–187
   PubMedGoogle Scholar
• Man D, Plosker H, Winland-Brown JE. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg 2001; 107: 229–237
   PubMed Web of Science ®Google Scholar
• Mazzucco L, Balbo V, Cattana E, Guaschino R, Borzini P. Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure. Vox Sang 2009; 97: 110–118
   PubMed Web of Science ®Google Scholar
• Kurane A, Vyavahare N. In vivo vascular tissue engineering: Influence of cytokine and implant location on tissue specific cellular recruitment. J Tissue Eng Regen Med 2009; 3: 280–289
   PubMedGoogle Scholar
• Tamama K, Kawasaki H, Wells A. Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC, J Biomed Biotechnol Volume 2010 (2010), Article ID 795385.
   Google Scholar
• Backen AC, Cummings J, Mitchell C, Jayson G, Ward TH, Dive C. 2009. ‘Fit -for-purpose' validation of SearchLight multiplex ELISAs of angiogenesis for clinical trial use. J Immunol Methods 2009; 342: 106–114
   PubMedGoogle Scholar
• Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008; 3: 301–313
   PubMed Web of Science ®Google Scholar
• Chen CW, Montelatici E, Crisan M, Corselli M, Huard J, Lazzari L, Péault B. Perivascular multi-lineage progenitor cells in human organs: Regenerative units, cytokine sources or both?. Cytokine Growth Factor Rev 2009; 20: 429–434
   PubMed Web of Science ®Google Scholar
• Morigi M, Rota C, Montemurro T, Montelatici E, Lo Cicero V, Imberti B, Abbate M, Zoja C, Cassis P, Longaretti L, et al. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Stem Cells 2010; 28: 513–522
   PubMed Web of Science ®Google Scholar
• Galiano RD, Tepper OM, Pelo CR, Bhatt KA, Callaghan M, Bastidas N, Bunting S, Steinmetz HG, Gurtner GC. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 2004; 164: 1935–1947
   PubMed Web of Science ®Google Scholar
• Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, Brem H. The role of vascular endothelial growth factor in wound healing. J Surg Res 2009; 153: 347–358
   PubMed Web of Science ®Google Scholar
• Beck LS, Deguzman L, Lee WP, Xu Y, McFatridge LA, Gillett NA, Amento EP. Rapid publication. TGF-beta1 induces bone closure of skull defects. J Bone Miner Res 1991; 6: 1257–1265
   PubMed Web of Science ®Google Scholar
• Tang Y, Wu X, Lei W, Pang L, Wan C, Shi Z, Zhao L, Nagy TR, Peng X, Hu J, et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 2009; 15: 757–765
   PubMed Web of Science ®Google Scholar